Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-15

Clinical Trial Update: Population-based Atrial Fibrillation Screening in Individuals With NT-proBNP Above Median in the Tromsø Study [NA]

View source ↗

Summary

This Tromsø Study-based clinical trial is evaluating population-based atrial fibrillation screening in individuals with NT-proBNP above the median to assess ear…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospital of North Norway | Conditions: Atrial Fibrillation (AF), Stroke | NA | Status: RECRUITING